Consistently in mouse models of progression of AKI caused by ischemia-reperfusion injury to CKD, Singh et al. [189] demonstrated that pharmacological inhibition of GSK3β using TDZD-8 significantly attenuated the development of renal fibrosis. Here, GSK3B is linked to chronic kidney disease.